1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Zimmermann, N.
Jung, G.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C3 H7 N O2
89.093
D-ALANINE
D-peptide linking
C4 H9 N O2
103.120
D-ALPHA-AMINOBUTYRIC ACID
D-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
IX
Eur.J.Biochem.
EJBCAI
0262
0014-2956
246
809
819
10.1111/j.1432-1033.1997.00809.x
9219543
The three-dimensional solution structure of the lantibiotic murein-biosynthesis-inhibitor actagardine determined by NMR.
1997
IX
Eur.J.Biochem.
EJBCAI
0262
0014-2956
228
786
10.1111/J.1432-1033.1995.TB20324.X
7737178
The Tetracyclic Lantibiotic Actagardine. 1H-NMR and 13C-NMR Assignments and Revised Primary Structure
1995
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1882.296
LANTIBIOTIC ACTAGARDINE
1
nat
polymer
no
yes
(DAL)SGWVC(DBB)L(DBB)IECG(DBB)VICAC
ASGWVCTLTIECGTVICAC
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
sample
31048, 31049
1
19
69484
Actinoplanes liguriensis
citation
entity_name_com
entity_src_nat
pdbx_database_status
struct_conn
struct_ref
struct_ref_seq
repository
Initial release
Version format compliance
Version format compliance
Atomic model
Database references
Derived calculations
Non-polymer description
Structure summary
Other
Database references
Derived calculations
Other
Source and taxonomy
Structure summary
1
0
1997-10-15
1
1
2011-06-14
1
2
2011-07-13
1
3
2011-07-27
1
4
2012-12-12
1
5
2019-12-11
_citation.page_last
_citation.pdbx_database_id_DOI
_citation.title
_entity_src_nat.pdbx_beg_seq_num
_entity_src_nat.pdbx_end_seq_num
_entity_src_nat.pdbx_ncbi_taxonomy_id
_entity_src_nat.pdbx_organism_scientific
_pdbx_database_status.process_site
_struct_conn.pdbx_leaving_atom_flag
_struct_ref.db_code
_struct_ref.db_name
_struct_ref.pdbx_align_begin
_struct_ref.pdbx_db_accession
_struct_ref_seq.pdbx_db_accession
SOLUTION STRUCTURE OF TYPE B LANTIBIOTICS MERSACIDIN IN MEOH/H2O MIXTURE
SOLUTION STRUCTURE OF TYPE B LANTIBIOTICS MERSACIDIN IN DPC MICELLES
SOLUTION STRUCTURE OF TYPE B LANTIBIOTICS MERSACIDIN BOUND TO LIPID II IN DPC MICELLES
CRYSTAL STRUCTURE OF THE TUPE B LANTIBIOTIC MERSACIDIN
SOLUTION STRUCTURE OF THE LANTIBIOTIC EPILANCIN 15X
SOLUTION STRUCTURE OF NISIN AND LIPID II COMPLEX
SOLUTION STRUCTURE OF THE LANTIBIOTIC CINNAMYCIN COMPLEXED WITH LYSOPHOSPHATIDYLETHANOLAMINE
SOLUTION STRUCTURE OF LCH-ALPHA PEPTIDE FROM TWO-COMPONENT LANTIBIOTIC SYSTEM LICHENICIDIN VK21 A1
SOLUTION STRUCTURE OF LCH-BETA PEPTIDE FROM TWO-COMPONENT LANTIBIOTIC LICHENICIDIN VK21 A2
Y
BNL
1997-05-14
REL
REL
Lantibiotic
ACTAGARDINE IS A TRICYCLIC PEPTIDE. POST TRANSLATIONAL MATURATION
OF LANTIBIOTICS INVOLVES THE ENZYMIC CONVERSION OF THR AND SER INTO
DEHYDRATED AMINO ACIDS AND THE FORMATION OF THIOETHER BONDS WITH
CYSTEINE. THE THIOETHER BONDS WITH CYSTEINE RESULT IN THREE
RING STRUCTURES. THIS IS FOLLOWED BY MEMBRANE TRANSLOCATION AND
CLEAVAGE OF THE MODIFIED PRECURSOR.
ACTAGARDINE
Oligopeptide
LEAST RESTRAINT VIOLATIONS, BEST RELAXATION MATRIX R- FACTORS
100
15
NOESY
3.0
296
K
REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE.
DISTANCE GEOMETRY, ITERATIVE RELAXATION MATRIX REFINEMENT, RESTRAINED MOLECULAR DYNAMICS
BOELENS,BONVIN
refinement
IRMA
structure solution
BRUKER UXNMR UXNMR
structure solution
BIOSYM FELIX 2.3
structure solution
BIOSYM NMRCHITECT NMRCHITECT
600
Bruker
AMX2-600
DAL
1
n
1
DAL
1
A
SER
2
n
2
SER
2
A
GLY
3
n
3
GLY
3
A
TRP
4
n
4
TRP
4
A
VAL
5
n
5
VAL
5
A
CYS
6
n
6
CYS
6
A
DBB
7
n
7
DBB
7
A
LEU
8
n
8
LEU
8
A
DBB
9
n
9
DBB
9
A
ILE
10
n
10
ILE
10
A
GLU
11
n
11
GLU
11
A
CYS
12
n
12
CYS
12
A
GLY
13
n
13
GLY
13
A
DBB
14
n
14
DBB
14
A
VAL
15
n
15
VAL
15
A
ILE
16
n
16
ILE
16
A
CYS
17
n
17
CYS
17
A
ALA
18
n
18
ALA
18
A
CYS
19
n
19
CYS
19
A
software_defined_assembly
PQS
1
monomeric
A
DBB
7
POST-TRANSLATIONAL MODIFICATION
A
DBB
7
THR
A
DBB
9
POST-TRANSLATIONAL MODIFICATION
A
DBB
9
THR
A
DBB
14
POST-TRANSLATIONAL MODIFICATION
A
DBB
14
THR
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
A
VAL
CYS
5
6
139.32
1
A
A
CYS
DBB
6
7
146.55
1
A
A
ALA
CYS
18
19
102.52
2
A
A
VAL
CYS
5
6
138.81
2
A
A
ALA
CYS
18
19
103.53
3
A
A
TRP
VAL
4
5
148.48
3
A
A
VAL
CYS
5
6
137.43
3
A
A
ALA
CYS
18
19
103.40
4
A
A
VAL
CYS
5
6
140.91
4
A
A
CYS
DBB
6
7
149.26
4
A
A
ALA
CYS
18
19
99.60
5
A
A
TRP
VAL
4
5
146.69
5
A
A
VAL
CYS
5
6
139.48
5
A
A
ALA
CYS
18
19
101.68
6
A
A
VAL
CYS
5
6
140.88
6
A
A
ALA
CYS
18
19
103.44
7
A
A
VAL
CYS
5
6
141.34
7
A
A
CYS
DBB
6
7
148.89
7
A
A
ALA
CYS
18
19
99.40
8
A
A
VAL
CYS
5
6
141.29
8
A
A
CYS
DBB
6
7
148.49
8
A
A
ALA
CYS
18
19
103.07
9
A
A
VAL
CYS
5
6
139.12
9
A
A
CYS
DBB
6
7
146.62
9
A
A
ALA
CYS
18
19
103.31
10
A
A
VAL
CYS
5
6
141.24
10
A
A
CYS
DBB
6
7
149.20
10
A
A
ALA
CYS
18
19
100.95
11
A
A
VAL
CYS
5
6
141.35
11
A
A
CYS
DBB
6
7
148.70
11
A
A
ALA
CYS
18
19
102.14
12
A
A
VAL
CYS
5
6
141.76
12
A
A
CYS
DBB
6
7
146.73
12
A
A
ALA
CYS
18
19
103.81
13
A
A
VAL
CYS
5
6
140.21
13
A
A
ALA
CYS
18
19
102.20
14
A
A
VAL
CYS
5
6
141.32
14
A
A
CYS
DBB
6
7
148.02
14
A
A
ALA
CYS
18
19
101.95
15
A
A
VAL
CYS
5
6
138.06
15
A
A
CYS
DBB
6
7
148.25
15
A
A
ALA
CYS
18
19
105.03
15
7.22
1.20
111.50
118.72
A
A
A
CB
CA
C
CYS
CYS
CYS
17
17
17
N
1
A
A
CD
OE2
GLU
GLU
11
11
0.119
0.011
1.252
1.371
N
1
A
A
C
OXT
CYS
CYS
19
19
0.200
0.019
1.229
1.429
N
2
A
A
CD
OE2
GLU
GLU
11
11
0.119
0.011
1.252
1.371
N
2
A
A
C
OXT
CYS
CYS
19
19
0.200
0.019
1.229
1.429
N
3
A
A
CD
OE2
GLU
GLU
11
11
0.119
0.011
1.252
1.371
N
3
A
A
C
OXT
CYS
CYS
19
19
0.200
0.019
1.229
1.429
N
4
A
A
CD
OE2
GLU
GLU
11
11
0.119
0.011
1.252
1.371
N
4
A
A
C
OXT
CYS
CYS
19
19
0.200
0.019
1.229
1.429
N
5
A
A
CD
OE2
GLU
GLU
11
11
0.119
0.011
1.252
1.371
N
5
A
A
C
OXT
CYS
CYS
19
19
0.199
0.019
1.229
1.428
N
6
A
A
CD
OE2
GLU
GLU
11
11
0.120
0.011
1.252
1.372
N
6
A
A
C
OXT
CYS
CYS
19
19
0.200
0.019
1.229
1.429
N
7
A
A
CD
OE2
GLU
GLU
11
11
0.119
0.011
1.252
1.371
N
7
A
A
C
OXT
CYS
CYS
19
19
0.199
0.019
1.229
1.428
N
8
A
A
CD
OE2
GLU
GLU
11
11
0.119
0.011
1.252
1.371
N
8
A
A
C
OXT
CYS
CYS
19
19
0.200
0.019
1.229
1.429
N
9
A
A
CD
OE2
GLU
GLU
11
11
0.120
0.011
1.252
1.372
N
9
A
A
C
OXT
CYS
CYS
19
19
0.200
0.019
1.229
1.429
N
10
A
A
CD
OE2
GLU
GLU
11
11
0.119
0.011
1.252
1.371
N
10
A
A
C
OXT
CYS
CYS
19
19
0.200
0.019
1.229
1.429
N
11
A
A
CD
OE2
GLU
GLU
11
11
0.119
0.011
1.252
1.371
N
11
A
A
C
OXT
CYS
CYS
19
19
0.200
0.019
1.229
1.429
N
12
A
A
CD
OE2
GLU
GLU
11
11
0.119
0.011
1.252
1.371
N
12
A
A
C
OXT
CYS
CYS
19
19
0.200
0.019
1.229
1.429
N
13
A
A
CD
OE2
GLU
GLU
11
11
0.120
0.011
1.252
1.372
N
13
A
A
C
OXT
CYS
CYS
19
19
0.199
0.019
1.229
1.428
N
14
A
A
CD
OE2
GLU
GLU
11
11
0.119
0.011
1.252
1.371
N
14
A
A
C
OXT
CYS
CYS
19
19
0.199
0.019
1.229
1.428
N
15
A
A
CD
OE2
GLU
GLU
11
11
0.120
0.011
1.252
1.372
N
15
A
A
C
OXT
CYS
CYS
19
19
0.200
0.019
1.229
1.429
N
1
A
VAL
5
-77.67
-75.92
1
A
CYS
6
52.47
119.22
1
A
LEU
8
-110.30
64.22
1
A
VAL
15
-139.02
-36.07
2
A
VAL
5
-78.40
-74.07
2
A
CYS
6
48.17
123.08
2
A
DBB
7
96.61
-34.64
2
A
LEU
8
-96.71
42.49
2
A
VAL
15
-135.97
-49.00
3
A
VAL
5
-79.20
-70.59
3
A
CYS
6
30.45
124.95
3
A
LEU
8
-115.97
61.26
3
A
VAL
15
-141.59
-33.95
4
A
VAL
5
-77.99
-76.19
4
A
CYS
6
49.71
120.05
4
A
DBB
7
97.17
-33.70
4
A
LEU
8
-98.27
55.33
4
A
VAL
15
-136.57
-51.07
5
A
VAL
5
-78.84
-74.64
5
A
CYS
6
38.11
121.09
5
A
LEU
8
-111.26
61.21
5
A
VAL
15
-136.57
-49.41
6
A
VAL
5
-78.54
-73.86
6
A
CYS
6
44.11
122.70
6
A
DBB
7
97.05
-33.19
6
A
LEU
8
-98.20
43.09
6
A
VAL
15
-135.98
-47.96
7
A
VAL
5
-77.84
-76.09
7
A
CYS
6
52.31
119.34
7
A
DBB
7
97.66
-33.97
7
A
LEU
8
-98.07
55.30
7
A
VAL
15
-136.57
-50.94
8
A
VAL
5
-77.81
-76.08
8
A
CYS
6
52.04
119.21
8
A
DBB
7
98.04
-33.35
8
A
LEU
8
-98.24
55.14
8
A
VAL
15
-140.63
-34.35
8
A
CYS
17
-79.52
-162.91
9
A
VAL
5
-77.69
-76.02
9
A
CYS
6
51.74
120.48
9
A
LEU
8
-107.63
63.11
9
A
VAL
15
-134.27
-50.02
10
A
VAL
5
-77.91
-75.65
10
A
CYS
6
48.35
117.75
10
A
LEU
8
-95.77
51.62
10
A
VAL
15
-137.37
-46.80
11
A
VAL
5
-77.78
-76.12
11
A
CYS
6
52.34
119.34
11
A
DBB
7
97.68
-33.98
11
A
LEU
8
-97.74
55.01
11
A
VAL
15
-134.18
-51.96
12
A
VAL
5
-77.82
-75.55
12
A
CYS
6
48.09
120.10
12
A
LEU
8
-110.27
64.53
12
A
VAL
15
-133.42
-48.88
13
A
VAL
5
-78.62
-74.15
13
A
CYS
6
47.22
123.36
13
A
DBB
7
96.52
-33.64
13
A
LEU
8
-97.85
53.71
13
A
VAL
15
-142.20
-33.76
13
A
CYS
17
-80.00
-166.13
14
A
VAL
5
-77.94
-75.61
14
A
CYS
6
48.13
120.16
14
A
LEU
8
-109.95
61.30
14
A
VAL
15
-136.30
-50.60
15
A
VAL
5
-78.55
-73.65
15
A
CYS
6
47.25
122.93
15
A
VAL
15
-132.44
-44.90
15
A
CYS
17
-86.60
-158.74
LANTIBIOTIC ACTAGARDINE
NMR STRUCTURE OF THE LANTIBIOTIC ACTAGARDINE
1
N
N
covale
1.350
both
A
DAL
1
A
C
DAL
1
1_555
A
SER
2
A
N
SER
2
1_555
covale
1.814
none
A
DAL
1
A
CB
DAL
1
1_555
A
CYS
6
A
SG
CYS
6
1_555
covale
1.318
one
A
CYS
6
A
C
CYS
6
1_555
A
DBB
7
A
N
DBB
7
1_555
covale
1.351
both
A
DBB
7
A
C
DBB
7
1_555
A
LEU
8
A
N
LEU
8
1_555
covale
1.843
none
A
DBB
7
A
CB
DBB
7
1_555
A
CYS
12
A
SG
CYS
12
1_555
covale
1.346
one
A
LEU
8
A
C
LEU
8
1_555
A
DBB
9
A
N
DBB
9
1_555
covale
1.823
none
A
DBB
9
A
CB
DBB
9
1_555
A
CYS
17
A
SG
CYS
17
1_555
covale
1.353
both
A
DBB
9
A
C
DBB
9
1_555
A
ILE
10
A
N
ILE
10
1_555
covale
1.348
one
A
GLY
13
A
C
GLY
13
1_555
A
DBB
14
A
N
DBB
14
1_555
covale
1.824
none
A
DBB
14
A
CB
DBB
14
1_555
A
CYS
19
A
SG
CYS
19
1_555
covale
1.358
both
A
DBB
14
A
C
DBB
14
1_555
A
VAL
15
A
N
VAL
15
1_555
ANTIBIOTIC
ANTIBIOTIC, LANTIBIOTIC, ANTIMICROBIAL, BACTERIOCIN, THIOESTER, TRANSMEMBRANE PORE
1AJ1
PDB
1
1
1AJ1
1
19
1AJ1
1
19
1AJ1
A
1
1
19
1
P 1